Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2004
04/15/2004WO2003053422A3 Method and compositions for treating respiratory pathologies
04/15/2004WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
04/15/2004WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
04/15/2004WO2003039449A3 Modulation of dopaminergic neurons
04/15/2004WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/15/2004WO2003026574A3 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
04/15/2004WO2003022844A9 Synthesis of epothilones intermediates thereto and analogues thereof
04/15/2004WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure
04/15/2004WO2003013433A3 Sequestered antagonist formulations
04/15/2004WO2003008038A9 Electro-medical device for use with biologics
04/15/2004WO2003006057A8 Composition and method for the treatment of disease
04/15/2004WO2003002059A3 Tolterodine metabolites
04/15/2004WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
04/15/2004WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
04/15/2004WO2002080962A8 Papaine containing pharmaceutical formulation resp. its use
04/15/2004WO2002069980A3 Pharmaceutically effective ginsenosides and their use
04/15/2004WO2002067854A3 Manufacture of thyroid hormone tablets having consistent active moiety amounts
04/15/2004WO2002060389A3 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
04/15/2004WO2002050090A8 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
04/15/2004WO2002043715A3 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
04/15/2004WO2002039999B1 Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition
04/15/2004WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
04/15/2004WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
04/15/2004WO2002000227A8 Use of lanthanum compounds for the treatment of bone diseases
04/15/2004WO2001070955A8 Identification of essential genes in prokaryotes
04/15/2004US20040073280 Method of controlling body temperature while reducing shivering
04/15/2004US20040073258 Body tissue and skin treatment method using pulsing heating pad and topical cream
04/15/2004US20040073190 Methods and devices for treating aneurysms
04/15/2004US20040073039 Blocking neurotransmitter
04/15/2004US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist
04/15/2004US20040073036 Substituted alkyl amido piperidines
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040073025 Thrombin inhibitors
04/15/2004US20040073024 Phosphorus-containing compounds and uses thereof
04/15/2004US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents
04/15/2004US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/15/2004US20040072915 Novel medicines based on sesquiterpene mixtures
04/15/2004US20040072914 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
04/15/2004US20040072913 Skin disorders; induce cell differentiation; using plant extract
04/15/2004US20040072912 Wet granulation; drying in fluidized bed; compression
04/15/2004US20040072911 Mixture of antiseptic, bactericide and lubricant
04/15/2004US20040072910 AIDS prophylactic lubricating composition
04/15/2004US20040072909 Veterinary compositions for the treatment of parasitic diseases
04/15/2004US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use
04/15/2004US20040072906 Adjust blood-sugar concentration using plant extract
04/15/2004US20040072905 Use of nitric oxide synthase inhibitors for the treatment of diabetes
04/15/2004US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches
04/15/2004US20040072903 Dyslipidemia therapy; antiischemic agents; prevent, delay cardiovascular disorders
04/15/2004US20040072902 Methods for inducing apoptosis and inhibiting proliferation in cancer cells
04/15/2004US20040072901 Corosolic acid formulation and its application for weight-loss management and blood sugar balance
04/15/2004US20040072900 Parkinson's disease; Alzheimer's diseases; Hintington's disease
04/15/2004US20040072898 Skin disorders; dentistry; heart transplantation
04/15/2004US20040072897 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders
04/15/2004US20040072896 Antiprotozoa agents
04/15/2004US20040072894 Anticholesterol agents; compressed into tablets
04/15/2004US20040072893 Antilipemic agents; anticholesterol agents
04/15/2004US20040072891 Urogenital disorders
04/15/2004US20040072890 Anticancer agents
04/15/2004US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
04/15/2004US20040072888 Administering pyrazoloanthrone compound
04/15/2004US20040072885 Treatments for immune-mediated ear disorders
04/15/2004US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
04/15/2004US20040072882 Methods to administer epothilone D
04/15/2004US20040072881 Dietetics; osteoporosis; muscular disorders
04/15/2004US20040072877 Using desaturase inhibitor; antidiabetic agents
04/15/2004US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
04/15/2004US20040072875 Use of parathyroid hormone-related protein (PTHrP) in the diagnosis and treatment of chronic lung disease and other pathologies
04/15/2004US20040072873 Therapy for drug resistant infections
04/15/2004US20040072871 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them
04/15/2004US20040072870 Anticancer agents
04/15/2004US20040072869 Bipolar disorders; psychological diseases
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents
04/15/2004US20040072866 Condensation, dehydration; factor x inhibitors
04/15/2004US20040072865 Anticholesterol agents; antidiabetic agents; antilipemic agents
04/15/2004US20040072864 Method and composition for treatment of irritable bowel disease
04/15/2004US20040072863 Novel quinuclidine derivatives and medicinal compositions containing the same
04/15/2004US20040072862 Compositions for treating ischemia-related neuronal damage
04/15/2004US20040072861 Anxiolytic agents
04/15/2004US20040072860 Piperazin-2-one amides as inhibitors of factor xa
04/15/2004US20040072859 Urea substituted imidazoquinoline ethers
04/15/2004US20040072855 Crystallization, mixing with solvent at low temperature; therapy for central nervous system disorders
04/15/2004US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents
04/15/2004US20040072853 Therapeutic compounds
04/15/2004US20040072852 Anticholesterol agents; cardiovascular disorders
04/15/2004US20040072851 Incontinence; benign prostatic hyperplasia
04/15/2004US20040072850 Caspase inhibitors and uses thereof
04/15/2004US20040072848 Methods of treating irritable bowel syndrome and functional dyspepsia
04/15/2004US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
04/15/2004US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
04/15/2004US20040072845 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl] piperazine
04/15/2004US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
04/15/2004US20040072841 Topical administration of oxazolidinones for transdermal delivery
04/15/2004US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
04/15/2004US20040072834 Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide
04/15/2004US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease
04/15/2004US20040072832 Anticancer agents; antiinflammatory agents
04/15/2004US20040072831 Reverse-turn mimetics and method relating thereto
04/15/2004US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents
04/15/2004US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists